[
    [
        {
            "time": "2021-08-23",
            "original_text": "复星医药上半年净利增44.77% 新冠疫苗复必泰贡献超5亿元收入",
            "features": {
                "keywords": [
                    "复星医药",
                    "新冠疫苗",
                    "复必泰",
                    "净利增长"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "复星医药上半年净利增44.77% 新冠疫苗复必泰贡献超5亿元收入",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-08-23",
            "original_text": "市值蒸发3000亿后，孙飘扬将把恒瑞医药带向何处？",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "孙飘扬",
                    "市值蒸发"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "市值蒸发3000亿后，孙飘扬将把恒瑞医药带向何处？",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-08-23",
            "original_text": "华北制药断供集采被重罚，中标与落选 “双重困境”下药企路在何方？",
            "features": {
                "keywords": [
                    "华北制药",
                    "断供",
                    "集采",
                    "重罚"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "华北制药断供集采被重罚，中标与落选 “双重困境”下药企路在何方？",
                "Correlation": 7,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-08-23",
            "original_text": "A股大幅反弹北向资金加仓超18亿，持续加码高景气板块",
            "features": {
                "keywords": [
                    "A股",
                    "北向资金",
                    "加仓",
                    "高景气板块"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "全市场"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "A股大幅反弹北向资金加仓超18亿，持续加码高景气板块",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-08-23",
            "original_text": "恒瑞医药半年报发出即跌停！走出创新转型阵痛期，恒瑞医药还有多远？",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "半年报",
                    "跌停",
                    "创新转型"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "恒瑞医药半年报发出即跌停！走出创新转型阵痛期，恒瑞医药还有多远？",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-08-23",
            "original_text": "业绩远低预期市值缩水超3000亿 恒瑞医药延续下跌态势 盈利能力下降",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "业绩低预期",
                    "市值缩水",
                    "盈利能力下降"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "业绩远低预期市值缩水超3000亿 恒瑞医药延续下跌态势 盈利能力下降",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 10,
                "Impact": 10,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-08-23",
            "original_text": "暴力反弹！创业板大涨2%，3000亿医药茅却创两年新低",
            "features": {
                "keywords": [
                    "创业板",
                    "医药茅",
                    "暴力反弹",
                    "两年新低"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "创业板"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "mixed"
            },
            "scores": {
                "News_content": "暴力反弹！创业板大涨2%，3000亿医药茅却创两年新低",
                "Correlation": 8,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        }
    ]
]